The eradication of polio as a global health threat may be delayed unless U.S. funding cuts – potentially totaling hundreds of ...

Currently, IPV is relatively expensive to produce because it requires high levels of bio-containment to minimise the risk of leaks of live poliovirus, which could result in outbreaks. VLPs are ...

University of Leeds researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine using virus-like particles (VLPs). These particles mimic the outer protein ...

According to healthychildren.org, childhood vaccines consistently remain at very high and beneficial levels of safety and efficacy.

POLIO has emerged as a major challenge in Pakistan. It is not simply a challenge in the health sector, but has also become ...

Coverage with measles-mumps-rubella (MMR), diphtheria-tetanus-acellular pertussis (DTaP), polio, and varicella, or chickenpox vaccines, all declined in more than 30 states last year compared with ...

Funding cuts, including the U.S. withdrawal from WHO, threaten the global fight against polio. Over $133 million expected ...

Topline data were announced from a phase 2/3 trial evaluating Flebogamma 5% DIF (immune globulin intravenous ) in patients with post-polio syndrome (PPS).

Grifols has announced positive results from its phase 2/3 clinical trial evaluating the efficacy and safety of intravenous ...

US-based PharmaJet, a company dedicated to enhancing injectable performance through needle-free injection technology, has ...